UAB MedCast

UAB Adds Surgery Suite with Built-In MRI

James Markert, MD, MPH - Speaker Bio
Dr. Markert is the Chair of the Department of Neurosurgery at University of Alabama at Birmingham, and has been a faculty member in neurological surgery for since 1996. He attended college at Harvard College in Cambridge, Massachusetts, then obtained his MD/MPH from the Columbia University College of Physicians and Surgeons and School of Public Health in New York City. Subsequently, he trained in Surgery and Neurological Surgery at the University of Michigan Medical Center.  Dr. Markert also completed a research fellowship at Massachusetts General Hospital in the area of molecular neurosurgery under the direction of Dr. Robert Martuza.  Following the completion of his residency, Dr. Markert took a position at University of Alabama at Birmingham in neurological surgery and simultaneously completed a research associate fellowship in the laboratory of National Academy of Science member, Dr. Bernard Roizman.  Dr. Markert's career has included clinical neurosurgery as well as laboratory and translational research to develop novel treatments for brain tumors;  he has also been active in the education of residents, medical students and undergraduates. Dr. Markert has been very active in organized neurosurgery on a national level, and currently serves as the Secretary of the American Academy of Neurological Surgeons. 

Learn more about Dr. Markert 

Release Date: April 22, 2022
Expiration Date: April 21, 2025

Disclosure Information:

Ronan O’Beirne, EdD, MBA
Director, UAB Continuing Medical Education

Katelyn Hiden
Physician Marketing Manager, UAB Health System

The planners have no relevant financial relationships with ineligible companies to disclose.

James Markert, MD, MPH
Chair, Department of Neurosurgery, James Garber Galbraith Endowed Chair

Dr. Markert has disclosed the following financial relationships with ineligible companies:
Grants/Research Support/Grants Pending - Gateway
Stock/Shareholder - Aettis, Treovir
Patents (planned, pending or issued) - Amgen
Royalties - Aettis, Royalty for IP

All relevant financial relationships have been mitigated. Dr. Markert does not intend to discuss the off-label use of a product. No other speakers, planners or content reviewers have any relevant financial relationships with ineligible companies to disclose.

There is no commercial support for this activity.
  • Topic Info:Procedures for brain tumors, epilepsy, and movement disorders require a precise and conservative approach so as not to damage functioning brain tissue. UAB Hospital neurosurgeons can now check their work as they operate in a new intraoperative MRI suite—the first in Alabama. James Markert, MD, MPH, chair of the Department of Neurosurgery in the Heersink School of Medicine, discusses how surgeons respond to real-time MRIs at crucial moments. Because of this technology, UAB surgeons can now target the margins of glioma tumors; confirm proper placement of deep brain stimulators for Parkinson’s disease; and use laser interstitial thermal therapy more precisely to eliminate seizures. Dr. Markert discusses the logistics of using an MRI in the operating suite and the vast potential of this suite for other surgical units.